Login to Your Account



Aslan aims to boost clinical capabilities with new facility

By Dave Silver
Staff Writer

Wednesday, February 19, 2014

TAIPEI, Taiwan – With Singapore-headquartered Aslan Pharmaceuticals Pte. Ltd. last week announcing that it had opened a new office here, the company has moved that much closer toward its goal of taking advantage of clinical trial infrastructure in Asia to develop novel medicines for global markets.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription